PDE inhibitor, GSK256066 2,2,2-trifluoroacetic acid, Purity ≥98%

Synonym: 1415560-64-3; GSK-256066; GSK 256066; 6-[3-(Dimethylcarbamoyl)phenyl]sulfonyl-4-(3-methoxyanilino)-8-methylquinoline-3-carboxamide; 2,2,2-trifluoroacetic acid; PDE inhibitor

CAS Number: 1415560-64-3
Compound CID: 71576691

Product Size

10 mg; 50 mg; 100 mg; 500 mg

Price

Datasheet

MSDS

Properties

Description

GSK256066 2,2,2-trifluoroacetic acid is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting PDE. The molecular weight of the compound is 632.61, and its molecular formula is C₂₉H₂₇F₃N₄O₇S.

Molecular Weight

632.61

Molecular Formula

C₂₉H₂₇F₃N₄O₇S

Form

Lyophilized powder

Purity

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Identity

Confirmed by NMR/HPLC/MS.

Applications

GSK256066 2,2,2-trifluoroacetic acid can be studied extensively for its potential therapeutic applications in the treatment of inflammatory diseases such as chronic obstructive pulmonary disease (COPD) and psoriasis.